Our editorial methodology
Not a compound file, but worth reading first: the five-criteria standard every guide on this register is held to.
See methodologyResearch and laboratory information only. Not for human consumption. We do not sell products or give medical advice.
No. 4 · The General Register
This register is where every verification guide we publish lives — starting with the fundamentals on this site, and growing into one dedicated file per compound: BPC-157, semaglutide, retatrutide, tirzepatide, in the order Dublin researchers ask about them. Information only, written from Dublin.
The compound files
We publish a guide once it meets our own methodology, not before. All four compound files are live — here's where each one leads.
Trial data, legal status and a step-by-step verification guide for Dublin researchers evaluating retatrutide sources.
Enter No. 1Purity thresholds, what an honest COA looks like, and the questions Dublin researchers ask most about this compound.
Enter No. 2How research-grade semaglutide is supplied for laboratory use, and where Dublin sourcing changes the picture.
Enter No. 3The newest compound on Dublin researchers' radar — what limited independent data exists, and how to read a COA for it.
Enter No. 4An eight-point verification checklist for the dual GIP/GLP-1 agonist, plus the red flags to watch for before you trust a listing.
EnterNot a compound file, but worth reading first: the five-criteria standard every guide on this register is held to.
See methodologyThe home page already covers what a Certificate of Analysis proves, and the honest version of how a parcel reaches Dublin — courier or import.